The World Health Organization defines menopause as the permanent cessation of menstruation
due to excessive loss of follicular parts (1). "Menopause" terminologically refers to the
last menstrual cycle. The "postmenopause" period follows the last menstrual cycle and
continues to restrict the 12-month period of amenorrhea (2). During the menopausal period,
signs and symptoms of formation may occur in structures sensitive to care (labia major/minor,
clitoris, introitus, vagina, urethra and environments). These signs and symptoms include
normal dryness, irritation of the vulva or vagina, vulvar and vaginal warmth such as burning,
smearing, decreased lubrication during sexual activity and dyspareunia and postcoital
bleeding, sexual reproduction such as decreased arousal and orgasm, and urinary problems such
as incontinence, dysuria, frequent stopping and urgency. It contains sections (3).
Approximately 50% of postmenopausal women are greatly affected in terms of both quality of
life and vital functionality (4,5). Topical hormonal therapy is normally considered standard
treatment for postmenopausal women. It ensures the epithelial integrity of women and the
restoration and vaginal proliferation of the vaginal flora. Prescription of topical risks
should also be avoided in patients with breast cancer, susceptible tumors and a history of
thromboembolism; This situation emphasizes the necessity of treatment alternatives (6,7).
Lubricants and moisturizers are options to help with drying, but sufficient data to screen
for effectiveness have not been published (7). It is another alternative to ospemifene and
breaks down the divisions depending on your hypoestrogen (8). Fractional CO 2 laser is an
emerging treatment option for vaginal care, especially for women with contraindications to
hormone therapy. Fractional CO 2 laser treatment consists of two or three sessions, and
treatment responses only occur after a period of 20 weeks (9). Another treatment approach is
pelvic floor exercises. Pelvic floor muscle training (PFMT) was first described as an
effective method of urinary incontinence management by Arnold Kegel in 1948 (10). Although
Kegel reports reported over 84% recovery rates for patients after PFMT, it remained the
first-stage treatment approach until the 1980s. Following this payment, women's incontinence,
health and sports opportunities, the cost of surgeries, the paths opened by the surgical
route, services and the permanent deterioration of the recurrences that occur after surgery,
and the interest in conservative treatments also come (11). In many systematic reviews, PFMT
is considered to be the first step in the treatment of urinary incontinence (12,13). A recent
single-arm feasibility study found a 12-week pelvic floor muscle training (PFMT) program, a
normal symptom of postmenopausal bleeding with urinary incontinence and significant bursts.
After the intervention, increased secretions in normal walls, thicker vaginal epithelial
cells, and improvement in vaginal color were achieved. In other words, postmenopausal pelvic
floor exercises increase vaginal secretions and restore normal size (14).
The purpose of this process is; To investigate the normal and sexual health status of pelvic
floor exercises after menopause. In addition, generally normal behaviors were evaluated by
observing them subjectively (9,15). In our study, we plan to evaluate normal dryness, which
is one of the normal conditions, using the Schirmer Test. Additionally, our study will be the
first to evaluate normal dryness of a lens.